Estimating the Budget Impact of Switching from Bortezomib...

Estimating the Budget Impact of Switching from Bortezomib Intravenous (Iv) to Bortezomib Subcutaneous (Sq) in the Treatment of Relapsed/Refractory Multiple Myeloma (Mm) in Mexico

Wehler, EA, Kowal, S, Hernandez-Garduno, A, Danese de los Santos, L, de Anda, JA, Anaya, P, Munakata, J, Gonzalez, L
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Journal:
Value in Health
DOI:
10.1016/j.jval.2015.09.244
Date:
November, 2015
File:
PDF, 51 KB
2015
Conversion to is in progress
Conversion to is failed